28
Views
0
CrossRef citations to date
0
Altmetric
Review Article

A review of the hepatotoxicity of paracetamol at therapeutic or near-therapeutic dose levels, with particular reference to alcohol abusers

&
Pages 63-79 | Received 30 Aug 1993, Accepted 24 Nov 1994, Published online: 12 Jul 2009

References

  • Ellenhorn MJ, Barceloux DG. Medical Toxicology. Elsevier, New York 1988; 156–166
  • Davidson DGD, Eastham WN. Acute liver necrosis following overdose of paracetamol. Br Med J 1966; 2: 497–499
  • Johnson GK, Tolman KG. Chronic liver disease and acetaminophen. Ann Intern Med 1977; 87: 302–304
  • Bonkowsky HL, Mudge GH, McMurtry RJ. Chronic hepatic inflammation and fibrosis due to low doses of paracetamol. Lancet 1978; ii: 1016–1018
  • Black M. Acetaminophen hepatotoxicity. Ann Rev Med 1984; 35: 577–593
  • MIMS Annual, Australia. Griffin Press Ltd, Sydney 1993
  • Hawton K, Fagg J. Trends in deliberate self poisoning and self injury in Oxford, 1976–90. Br Med J 1992; 304: 1409–1411
  • Henry J, Volans G. Analgesics: II-Paracetamol. Br Med J 1984; 289: 907–908
  • Slattery JT, Koup JR, Levy G. Acetaminophen pharmacokinetics after overdose. Clin Toxicol 1981; 18: 111–117
  • Slattery JT, Wilson JM, Kalhorn TF, Nelson SD. Dose-dependent pharmacokinetics of acetaminophen: evidence of glutathione depletion in humans. Clin Pharmacol Ther 1987; 41: 413–418
  • Nelson E, Morioka T. Kinetics of the metabolism of acetaminophen by humans. J Pharm Sci 1963; 52: 864–868
  • Rumore MM, Blaiklock RG. Influence of age-dependent pharmacokinetics and metabolism on acetaminophen hepatotoxicity. J Pharm Sci 1992; 81: 203–207
  • Moldeus P, Larsson R, Ross D. Involvement of prostaglandin synthetase in the metabolic activation of acetaminophen and phenacetin. Arachidonic acid metabolism and tumour initiation, LJ Marnett. Martinus Nijhoff Publishing, Boston 1985; 171–198, In
  • Davis M. Protective agents for acetaminophen overdose. Semin Liver Dis 1986; 6: 138–147
  • Raucy JL, Lasker JM, Lieber CS, Black M. Acetaminophen activation by human liver cytochromes P-45011E1 and P4501A2. Arch Biochem Biophys 1989; 271: 270–283
  • Jollow DJ, Mitchell JR, Potter WZ, Davis DC, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. 11. Role of covalent binding in vivo. J Pharmacol Exp Ther 1973; 187: 195–202
  • Potter WZ, Davis DC, Michell JR, Jollow DJ, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. 111. Cytochrome P450-mediated covalent binding in vitro. Pharmacol Exp Ther 1973; 187: 203–210
  • Bartalone JB, Sparks K, Cohen SD, Khairallah EA. Immunochemical detection of acetaminophen-bound liver proteins. Biochem Pharmacol 1987; 36: 1193–1196
  • Roberts DW, Pumford NR, Potter DW, Benson RW, Hinson JA. A sensitive immunochemical assay for acetaminophen-protein adducts. Pharmacol Exp Ther 1987; 241: 527–533
  • Axworthy DB, Hoffman KJ, Streeter AJ, Calleman CJ, Pascoe GA, Baillie TA. Covalent binding of acetaminophen to mouse hemoglobin. Identification of major and minor adducts formed in vivo and implications for the nature of arylating metabolites. Chem Biol Interact 1988; 68: 99–116
  • Nelson SD. Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin Liver Dis 1990; 10: 267–278
  • Tsokos-Kuhn JO, Hughes H, Smith CV, Mitchell JR. Alkylation of the liver plasma membrane and inhibition of the Ca++ ATPase by acetaminophen. Biochem Pharmacol 1988; 37: 2125–2131
  • Tirmenstein MA, Nelson SD. Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a non hepatotoxic regioisomer, 3-hydroxyacetanilide, in mouse liver. J Biol Chem 1989; 264: 9814–9819
  • Pascoe GA, Fariss MW, Olafsdottir K, Reed DJ. A role of vitamin E in protection against cell injury. Maintenance of intracellular glutathione precursors and biosynthesis. Eur J Biochem 1987; 166: 241–247
  • McLean AEM, Day PA. The effect of diet on the toxicity of paracetamol and the safety of paracetamol-methionine mixtures. Biochem Pharmacol 1975; 24: 37–42
  • Walker BE, Kelleher J, Dixon MF, Losowsky MS. Vitamin E protection of the liver from paracetamol in the rat. Clin Sci and Mol Med 1974; 47: 449–459
  • Ben-Zvi Z, Weissman-Teitellman B, Katz S, Danon A. Acetaminophen hepatotoxicity: Is there a role for prostaglandin synthesis. Arch Toxicol 1990; 64: 299–304
  • Prescott LF. Liver damage with non-narcotic analgesics. Med Toxicol 1986, Suppl 1: 44–56
  • Lauterburg BH, Corcoran GB, Mitchell JR. Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J Clin Invest 1983; 71: 980–991
  • Corcoran GB, Wong BK. Role of glutathione in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-L-cysteine in vivo: Studies with N-acetyl-D-cysteine in mice. J Pharmacol Exp Ther 1986; 238: 54–61
  • Penna A, Buchanan N. Paracetamol poisoning in children and hepatotoxicity. Br J Clin Pharmacol 1991; 32: 143–149
  • Tee LGB, Boobis AR, Davies DS. N-acetylcysteine for paracetamol overdose. Lancet 1986; 1: 331–332
  • Parker D, White JP, Paton D, Routledge PA. Safety and late acetylcysteine treatment in paracetamol poisoning. Hum Exp Toxicol 1990; 9: 25–27
  • Brovo-Fernandez EF, Reddy KR, Jeffers L, Schiff ER. Hepatotoxicity after prolonged use of acetaminophen: a case report. Bol Assoc Med P R 1988; 80: 417–419
  • Barker JD, de Carle DJ, Anuras S. Chronic excessive acetaminophen use and liver damage. Ann Intern Med 1977; 87: 299–301
  • Fernandez E, Fernandez-Brito AC. Acetaminophen toxicity. N Engl J Med 1977; 296: 577–577
  • Wong V, Daly M, Boon A, Heatley V. Paracetamol and acute biliary pain with cholestasis. Lancet 1993; 342: 869–869
  • Patel F. The fatal paracetamol dosage—how low can you go?. Med Sci Law 1992; 32: 303–310
  • Seeff LB, Cuccherini BA, Zimmerman HJ, Alder E, Benjamin SB. Acetaminophen hepatotoxicity in alcoholics. Ann Intern Med 1986; 104: 399–404
  • Kaysen GA, Pond SM, Roper MH, Menke DJ. Combined hepatic and renal injury in alcoholics during therapeutic use of acetaminophen. Arch Intern Med 1985; 145: 2019–2023
  • Edwards R, Oliphant J. Paracetamol toxicity in chronic alcohol abusers—a plea for greater consumer awareness. NZ Med J 1992; 105: 174–175
  • Licht H, Seeff LB, Zimmerman HJ. Apparent potentiation of acetaminophen hepatotoxicity by alcohol. Ann Intern Med 1980; 92: 511–511
  • LaBrecque DR, Mitros FA. Increased hepatotoxicity of acetaminophen in the alcoholic. Gastroenterology 1980; 78: 1310–1310
  • McClain CJ, Holtzman J, Allen J, Kromhout J, Shedlofsky S. Clinical features of acetaminophen toxicity. J Clin Gastroenterol 1988; 10: 76–80
  • Kumar S, Rex DK. Failure of physicians to recognise acetaminophen hepatotoxicity in chronic alcoholics. Ann Intern Med 1991; 151: 1189–1191
  • Wootton FT, Lee WM. Acetaminophen hepatotoxicity in the alcoholic. South Med J 1990; 83: 1047–1049
  • Kartsonis A, Reddy KR, Schiff ER. Alcohol, acetaminophen, and hepatic necrosis. Ann Intern Med 1986; 105: 138–139
  • McClain CJ, Kromhout JP, Peterson FJ, Holtzman JL. Potentiation of acetaminophen hepatotoxicity by alcohol. JAMA 1980; 244: 251–253
  • Denison H, Kaczynski J, Wallerstedt S. Paracetamol medication and alcohol abuse: a dangerous combination for the liver and the kidney. Scand J Gastroenterol 1987; 22: 701–704
  • O'Dell JR, Zetterman RK, Burnett DA. Centrilobular hepatic fibrosis following acetaminophen-induced hepatic necrosis in an alcoholic. JAMA 1986; 255: 2636–2637
  • Keaton MR. Acute renal failure in an alcoholic during therapeutic acetaminophen ingestion. South Med J 1988; 81: 1163–1166
  • Gerber MA, Kaufmann H, Klion F, Alpert LI. Acetaminophen associated hepatic injury. Hum Pathol 1980; 11: 37–42
  • Erickson RA, Runyon BA. Acetaminophen hepatotoxicity associated with alcoholic pancreatitis. Arch Intern Med 1984; 144: 1509–1509, 1513
  • Leist MH, Gluskin LE, Payne JA. Enhanced toxicity of acetaminophen in alcoholics: reports of three cases. J Clin Gastroenterol 1985; 7: 55–59
  • Levinson M. Ulcer, back pain, and jaundice in an alcoholic. Hosp Pract (Off Ed) 1983; 18: 48N–48N, 48S
  • Floren Ch, Thesleff P, Nilsson A. Severe liver damage caused by therapeutic doses of acetaminophen. Acta Med Scand 1987; 222: 285–288
  • Johnson MW, Friedman PA, Mitch WE. Alcoholism, non prescription drugs and hepatotoxicity. Am J Gastroenterol 1981; 76: 530–533
  • Fleckenstein JL. Nyquil and acute hepatic necrosis. New Engl J Med 1985; 313: 48–48
  • Sivaloganathan K, Johnson PA, Bray GP, Williams R. Pericoronitis and accidental paracetamol overdose: a cautionary tale. Br Dent J 1993; 174: 69–71
  • Goldfinger R, Ahmed KS, Pitchumoni CS, Weseley SA. Concomitant alcohol and drug abuse enhancing acetaminophen toxicity. Am J Gastroenterol 1978; 70: 385–388
  • Lesser PB, Vietti MM, Clark WD. Lethal enhancement of therapeutic doses of acetaminophen by alcohol. Dig Dis Sci 1986; 31: 103–105
  • Emby DJ, Fraser BN. Hepatotoxicity of paracetamol enhanced by ingestion of alcohol. S Afr Med J 1977; 51: 208–209
  • Black M, Cornell JF, Rabin L, Shachter N. Late presentation of acetaminophen hepatotoxicity. Dig Dis Sci 1982; 27: 370–374
  • Himmelstein DU, Woolhandler SJ, Adler RD. Elevated SGOT/SGPT ratio in alcoholic patients with acetaminophen hepatotoxicity. Am J Gastroenterol 1984; 79: 718–720
  • Pirotte JH. Apparent potentiation by phenobarbital of hepatotoxicity from small doses of acetaminophen (letter). Ann Intern Med 1984; 101: 403–403
  • Olsson R. Increased hepatic sensitivity to paracetamol. Lancet 1978; i: 152–153
  • Sacher M, Thaler H. Toxic hepatitis after therapeutic doses of Benorylate and D-penicillamine. Lancet 1977; i: 481–481
  • Murphy R, Swatz R, Watkins PB. Severe acetaminophen toxicity in a patient receiving isoniazid. Ann Intern Med 1990; 113: 799–800
  • Crippin JS. Acetaminophen hepatotoxicity: Potentiation by isoniazid. Am J Gastroenterol 1993; 88: 590–591
  • Wilson JT, Kasantikul V, Harbison R, Martin D. Death in an adolescent following an overdose of acetaminophen and phenobarbital. Am J Dis Child 1978; 132: 466–473
  • Ackerman Z, Flugelman MY, Wax Y, Shouval D, Levy M. Hepatitis during measles in young adults: possible role of antipyretic drugs. Hepatology 1989; 10: 203–206
  • Rosenberg DM, Meyer AA, Manning IH, Neelon FA. Acetaminophen and hepatic dysfunction in infectious mononucleosis. South Med J 1977; 70: 660–661
  • Davis AM, Helms CM, Mitros FA, Wong YW, LaBrecque DR. Severe hepatic damage after acetaminophen use in Psittacosis. Am J Med 1983; 74: 349–352
  • Editorial. Aspirin or Paracetamol. Lancet 1981; 2: 287–289
  • Friis H, Andreasen PB. Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse drug reactions between 1978 and 1987. J Intern Med 1992; 232: 133–138
  • Dietz AJ, Carlson JD, Wahbakhalil SK, Nygard G. Effects of alcoholism on acetaminophen pharmacokinetics in man. J Clin Pharmacol 1984; 24: 205–208
  • Peterson FJ, Holloway DE, Erickson RR, Duquette PH, McClain CJ, Holtzman JL. Ethanol induction of acetaminophen toxicity and metabolism. Life Sci 1980; 27: 1705–1711
  • Moldeus P, Andersson B, Norling A, Ormstad K. Effect of chronic alcohol administration on drug metabolism in isolated hepatocytes with emphasis on paracetamol activation. Biochem Pharmacol 1980; 29: 1741–1745
  • Sato C, Matsuda Y, Lieber CS. Increased hepatotoxicity of acetaminophen after chronic ethanol consumption in the rat. Gastroenterology 1981; 80: 140–148
  • Lieber CS. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. N Eng J Med 1988; 319: 1639–1650
  • Morgan ET, Koop DR, Coon MJ. Comparison of six rabbit liver cytochrome P-450 isozymes in formation of a reactive metabolite of acetaminophen. Biochem Biophys Res Commun 1983; 112: 8–13
  • Thummel KE, Lee CA, Kunze KL, Nelson SD, Slattery JT. Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP 3A4. Biochem Pharmacol 1993; 45: 1563–1569
  • Wright N, Prescott LF. Potentiation by previous drug therapy of hepatotoxicity following paracetamol overdose. Scot Med J 1973; 18: 56–58
  • Vendemaile G, Altamore E, Lieber CS. Altered biliary excretion of acetaminophen in rats fed ethanol chronically. Drug Metab Dispos 1984; 12: 20–24
  • Tredger JM, Smith HM, Read RB, Portmann B, Williams R. Effects of ethanol ingestion on the hepatotoxicity and metabolism of paracetamol in mice. Toxicology 1985; 36: 341–352
  • Tredger JM, Smith HM, Read RB, Williams R. Effects of ethanol ingestion on the metabolism of a hepatotoxic dose of paracetamol in mice. Xenobiotica 1986; 16: 661–670
  • Lauterburg BH, Velez MA. Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity. Gut 1988; 29: 1153–1157
  • Prescott LF, Critchley JA. Drug interactions affecting analgesic toxicity. Am J Med 1983; 75: 113–116
  • Boxill GC, Nash CB, Wheeler AG. Comparative pharmacological and toxicological evaluation of N-acetyl-P-aminophenol, salicylamide and acetylsalicylic acid. J Am Pharm Assoc (Scient ed) 1958; 47: 479–487
  • McLean AEM, Day PA. The effect of diet on the toxicity of paracetamol and the safety of paracetamol-methionine mixtures. Biochem Pharmacol 1975; 24: 37–42
  • Suga T, Ohata I, Akagi M. Studies on mercapturic acids. Effect of some aromatic compounds on the level of glutathione and the activity of glutathione in the rat. J Biochem (Tokyo) 1966; 59: 209–215
  • Lauterburg BH, Vaishano Y, Stillwell WG, Mitchell JR. The effects of age and glutathione depletion on hepatic glutathione turnover in vivo determined by acetaminophen probe analysis. J Pharmacol Exp Ther 1980; 213: 54–58
  • Benson GD. Acetaminophen in chronic liver disease. Clin Pharmacol Ther 1983; 33: 95–101
  • Andreasen PB, Hutters L. Paracetamol (acetaminophen) clearance in patients with cirrhosis of the liver. Acta Med Scand 1979; 624: 99–105
  • Forrest JAH, Adrianssens P, Finlayson NDC, Prescott LF. Paracetamol metabolism in chronic liver disease. Eur J Clin Pharmacol 1979; 15: 427–431
  • Bray GP, Harrison PM, O'Grady JG, Tredger JM, Williams R. Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure. Hum Exper Toxicol 1992; 11: 265–270
  • Mitchell JR, Jollow DJ, Potter WZ, Davis DC, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. 1 Role of drug metabolism. J Pharmacol Exp Ther 1973; 187: 185–194
  • Miners JO, Attwood J, Birkett DJ. Determinants of acetaminophen metabolism: Effect of inducers and inhibitors of drug metabolism on acetaminophen's metabolic pathways. Clin Pharmacol Ther 1984; 35: 480–486
  • Ryan DE, Koop DR, Thomas PE, Coon MJ, Levin W. Evidence that isoniazid and ethanol induce the same microsomal cytochrome P-450 in rat liver, an isozyme homologous to rabbit liver cytochrome P-450 isozyme 3a. Arch Biochem Biophys 1986; 246: 633–644
  • Burk RF, Hill KE, Hunt RW, Martin AE. Isoniazid potentiation of acetaminophen hepatotixicity in the rat and 4-methylpyrazole inhibition of it. Res Commun Chem Path Pharmacol 1990; 69: 115–122
  • Mitchell JR, McMurtry RJ, Nelson SD. Glutathione and drug-induced tissue lesions. Glutathione: Metabolism and Function, IM Arias, WB Jakoby. Raven Press, New York 1976; 357–365, In
  • Epstein MM, Slattery JT, Nelson SD, Kalhorn TF, Wall RA, Wright JM. Inhibition of the metabolism of acetaminophen by isoniazid. Pharmacologist 1989; 31: 115–115
  • MacDonald MG, McGrath PP, McMartin DN, Washington GC, Hudak G. Potentiation of the toxic effects of acetaminophen in mice by concurrent infection with Influenza B virus: a possible mechanism for human Reye's syndrome?. Pediatr Res 1984; 18: 181–187
  • Buhl R, Jaffe HR, Holroyd KJ, Wells FB, Mastrangeli A, Saltini C, Cantin AM, Crystal RG. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 1989; ii: 1294–1294
  • Henry JA. Glutathione and HIV infection (Letter to the Editor). Lancet 1990; 335: 235–236
  • Shriner K, Goetz MB. Severe hepatotoxicity in a patient receiving both acetaminophen and zidovudine. Am J Med 1992; 93: 94–96
  • Hughes-Davies TH. Paracetamol hepatotoxicity. Lancet 1976; 1: 35–35
  • Hall AH, Kulig KW, Rumack BH. Acetaminophen hepatotoxicity. JAMA 1986; 256: 1893–1894
  • Hall AH, Kulig KW, Rumack BH. Acetaminophen hepatotoxicity in alcoholics. Ann Intern Med 1986; 105: 624–625
  • Rex DK, Kumar S. Recognizing acetaminophen hepatotoxicity in chronic alcoholics. Postgrad Med 1992; 91: 241–245
  • Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GJM, Williams R. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. Br Med J 1991; 303: 1026–1029
  • McLean AEM. Prevention of paracetamol poisoning. Lancet 1974; 1: 729–729
  • Neuvonen PJ, Tokola O, Toivonen M-L, Simell O. Methionine in paracetamol tablets, a tool to reduce paracetamol toxicity. Intern J Clin Pharmacol Ther Toxicol 1985; 23: 497–500
  • Savage SJ. Liver failure induced by paracetamol. Br Med J 1993; 306: 457–457
  • Spooner J. Liver failure induced by paracetamol. Br Med J 1993; 306: 457–458

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.